Market Research Logo

Global Newborn Screening Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Newborn Screening Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

The global newborn screening market is estimated to grow with the CAGR of approx. 12% during the forecast period (2016 – 2023). The factors that are influencing the growth of newborn screening market are increasing prevalence of newborn diseases, government support towards newborn child health, rising awareness for pediatric congenital heart disease and technological advancements in newborn screening. Currently, newborn screening (NBS) is the highest population-based genetic screening effort in the U.S. and is performed globally. The Centers for Disease Control and Prevention (CDC) has recognized newborn screening as 1 of the 10 major public health achievements in the U.S. during the first decade of the 21st century. The newborn screening programs are intended to detect asymptomatic newborns, which are at greater risk for particular diseases from those who might not, utilizing DBS specimens gathered 24 to 72 hours later birth. Babies which are screened positive are speedily followed up by the diagnostic confirmation and suitable treatment provides to prevent premature death, mental retardation and various deleterious clinical outcomes. Developments in the technology and the growth of the acclaimed uniform NBS panel of diseases led to lifesaving treatment and involvement for minimum 12,000 additional newborns every year in the U.S. with selected genetic, endocrine disorders and hearing.

Geographically, North America is leading the newborn screening market due to high awareness regarding newborn diseases coupled with CDC support to reduce the prevalence of such diseases supports to drive the demand for newborn screening market in the region. However, Asia Pacific is expected to be the fastest growing region for the market due to increasing fertility rates and newborn death rates in the region. The presence of major players such as Bio-Rad Laboratories, Inc., Medtronic PLC, Thermo Fisher Scientific, Inc., Perkinelmer, Inc. and Trivitron Healthcare Pvt Ltd etc. so on are creating opportunity for advances in newborn screening market.

The global newborn screening market is segmented into product type, test type and technology. Based on product type, the market is further classified into newborn disorder screening instruments, newborn hearing screening instruments, reagents & assay kits and pulseoximetry screening. Based on test type, the market is further classified into hearing screen test, critical congenital heart disease (CCHD) test and dry blood spot test. Based on technology, the market is further classified into hearing screen technology, electrophoresis, tandem mass spectrometry, pulse oximetry technology, DNA based assays and enzymes & immunoassays.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL NEWBORN SCREENING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING PREVALENCE OF NEWBORN DISEASES
3.1.2. GOVERNMENT SUPPORT TOWARDS NEWBORN CHILD HEALTH
3.1.3. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
3.1.4. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
3.2. MARKET RESTRAINTS
3.2.1. LACK OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
3.2.2. SOCIO-ECONOMIC BARRIERS IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING FERTILITY RATES ACROSS THE GLOBE.
3.3.2. UNTAPPED OPPORTUNITY IN DEVELOPING COUNTRIES
3.4. MARKET CHALLENGES
3.4.1. LACK OF SKILLED PROFESSIONALS
4. MARKET SEGMENTATION
4.1. GLOBAL NEWBORN SCREENING MARKET BY PRODUCT TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET
4.1.5.1.1. APPLICATION
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL NEWBORN HEARING SCREENING INSTRUMENTS MARKET
4.1.5.2.1. APPLICATION
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL NEWBORN SCREENING REAGENTS & ASSAY KITS MARKET
4.1.5.3.1. APPLICATION
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. GLOBAL NEWBORN PULSEOXIMETRY SCREENING MARKET
4.1.5.4.1. APPLICATION
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
4.2. GLOBAL NEWBORN SCREENING MARKET BY TEST TYPE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL HEARING SCREEN TEST MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL DRY BLOOD SPOT TEST MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL HEARING SCREEN TECHNOLOGY MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL ELECTROPHORESIS MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL TANDEM MASS SPECTROMETRY MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET
4.3.5.4.1. APPLICATION
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.3.5.5. GLOBAL DNA BASED ASSAYS MARKET
4.3.5.5.1. APPLICATION
4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.5.5. KEY CONCLUSIONS
4.3.5.6. GLOBAL ENZYMES & IMMUNOASSAYS MARKET
4.3.5.6.1. APPLICATION
4.3.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.6.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL NEWBORN SCREENING MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. AB SCIEX LLC (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. AGILENT TECHNOLOGIES, INC. (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. BIO TEK INSTRUMENTS, INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. BIO-RAD LABORATORIES, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. CARDINAL HEALTH, INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. GE HEALTHCARE (UK)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. MASIMO CORPORATION (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. MEDTRONIC PLC (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. NATUS MEDICAL, INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. NEOGEN LABS PVT. LTD. (INDIA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. PERKINELMER, INC. (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. THERMO FISHER SCIENTIFIC, INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. TRIVIRON HEALTHCARE PVT. LTD. (INDIA)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. WATERS CORPORATION (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. ZEN TECH S.A. (BELGIUM)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL NEWBORN SCREENING MARKET BY PRODUCT TYPE 2014-2023 ($ MILLION)
GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEWBORN HEARING SCREENING INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEWBORN SCREENING REAGENTS & ASSAY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEWBORN PULSEOXIMETRY SCREENING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEWBORN SCREENING MARKET BY TEST TYPE 2014-2023 ($ MILLION)
GLOBAL HEARING SCREENING TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL DRY BLOOD SPOT TEST MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
GLOBAL HEARING SCREEN TECHNOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL ELECTROPHORESIS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TANDEM MASS SPECTROMETRY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL DNA BASED ASSAYS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL ENZYMES & IMMUNOASSAYS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
EUROPE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET 2014-2023 ($ MILLION)
GLOBAL NEWBORN HEARING SCREENING INSTRUMENTS MARKET 2014-2023 ($ MILLION)
GLOBAL NEWBORN SCREENING REAGENTS & ASSAY MARKET 2014-2023 ($ MILLION)
GLOBAL NEWBORN PULSEOXIMETRY SCREENING MARKET 2014-2023 ($ MILLION)
GLOBAL HEARING SCREENING TEST MARKET 2014-2023 ($ MILLION)
GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET 2014-2023 ($ MILLION)
GLOBAL DRY BLOOD SPOT TEST MARKET 2014-2023 ($ MILLION)
GLOBAL HEARING SCREEN TECHNOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL ELECTROPHORESIS MARKET 2014-2023 ($ MILLION)
GLOBAL TANDEM MASS SPECTROMETRY MARKET 2014-2023 ($ MILLION)
GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL DNA BASED ASSAYS MARKET 2014-2023 ($ MILLION)
GLOBAL ENZYMES & IMMUNOASSAYS MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
CANADA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
FRANCE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
GERMANY NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
SPAIN NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
ROE NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
INDIA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
CHINA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
JAPAN NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
AUSTRALIA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
ROAPAC NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
LATIN AMERICA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)
MENA NEWBORN SCREENING MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report